NCT00517413View on ClinicalTrials.gov

LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Anemia
Interventions
DRUG

methoxy polyethylene glycol-epoetin beta [Mircera]

120, 200 or 360 micrograms sc or iv monthly, starting dose

Trial Locations (28)

0

Bogotá

1060

Caracas

1062

Caracas

1155

Buenos Aires

1437

Buenos Aires

1663

Buenos Aires

1824

Buenos Aires

2569

Quito

3000

Santa Fe

4002

Maracaibo

5000

Córdoba

11520

Mexico City

11600

Montevideo

11800

Montevideo

14000

Mexico City

14050

Mexico City

62448

Cuernavaca

64710

Monterrey

49055-210

Aracajú

80050-350

Curitiba

60430-370

Fortaleza

05624-000

São Paulo

056

Santiago

Unknown

Bogotá

03900

Mexico City

C 01

Callao

C01

Callao

L13

Lima

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00517413 - LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. | Biotech Hunter | Biotech Hunter